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in this issue of the Journal, Dunlay et al. (1) assessed the
requency, reasons, and risk factors for hospitalizations in
atients with heart failure (HF). The work is unique
ecause they assessed the lifetime burden of hospitalizations
n a population-based cohort of incident HF identified by
iagnosis, not from time of HF hospitalization, which has
reviously dominated our research and understanding. An
dditional strength is the high rate of characterization of
jection fraction. Placing this article in the context of
revious studies highlights the crucial importance of 2
istinctions: 1) many hospitalizations in patients with HF
re not “HF hospitalizations;” and 2) the number of
ospitalizations is higher than the number of patients
ospitalized, due to the “frequent flyer” cohort.
See page 1695
requency and Reasons for Hospitalizations
opulation studies have demonstrated that hospitalizations
n HF patients are frequent, and many are due to non-HF
easons. The current study found that 83% (895) of patients
iagnosed with heart failure had at least 1 hospitalization,
esulting in a total of 4,359 hospitalizations over a mean
ollow-up of 4.7 years. However, only 17% (713) of these
ospitalizations were attributed to HF, and these clustered
mong 32% of the patients (1). This provides a longer view
han a previous 1-year study of Medicare patients identified
y HF diagnosis, of whom 59% had hospitalizations in 1
ear, with 24% due to HF (2).
Most studies instead begin tracking after a HF hospital-
zation (1 HF hospitalizations) and show a high rate of
arly rehospitalizations (3–5) (Table 1), of which about
wo-thirds are attributed to cardiovascular (CV) causes (3).
hen we focus on those with a first hospitalization for HF,
-year rehospitalization was still common: 69% for any
eason (4), 44% to 50% for CV reasons (4,5), and 14% to
0% for HF (4–6). In patients with 2 HF hospitaliza-
ions, further analyses from the previous report of hospital-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.p
From the Divisions of †Pharmacoepidemiology and Pharmacoeconomics and
Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts.zations in British Columbia demonstrate that the overall
ehospitalization rate was similar (60% in 1 year) (4).
lmost all rehospitalizations were for cardiovascular reasons
96%), and many were due to HF (60%). Considering the
ifference in the criteria of patient identification between
he current and previous studies, these data confirm that
atients identified by hospitalization for HF have a higher
isk of repeated hospitalizations and that multiple HF
ospitalizations are clustered within these patients.
redicting Hospitalizations
he current study showed that male sex, diabetes, chronic
ulmonary disease, anemia, and renal dysfunction predict
ospitalization for any reason (1). Previous studies found
hat advanced age (3,7,8), noncardiac comorbidities such as
hronic kidney disease (3,7,8), chronic pulmonary disease
3,7), diabetes (7), depression (7), and prior hospitalizations
3,8) predict all-cause hospitalizations. We found that the
ssociation between repeated hospitalizations and mortality
as attenuated by advanced age and chronic kidney disease,
ndirectly suggesting that these factors predict repeated HF
ospitalizations (4). The risk of hospitalization was similar
n patients with and without systolic dysfunction (1,6).
ortality After Hospitalizations
istory of an HF hospitalization, the number of HF
ospitalizations, and shorter time to HF hospitalization are
ll associated with high mortality in trial patients (9,10). In
ommunity patients with HF, the mortality significantly
ncreased after each HF hospitalization (4), which is similar
n HF with and without systolic dysfunction (5). The data
n non-HF hospitalizations are conflicting: 1 large
opulation-based study found that mortality is increased by
epeated hospitalizations if due to HF or myocardial infarc-
ion, but not other CV diagnoses (4), whereas another
xperience found a similar effect on mortality after rehospi-
alization for any CV diagnoses (5). Hospitalizations in
atients with HF may serve as markers for disease progres-
ion, may reflect limited patient and health care system
apacity, or may themselves increase mortality due to the
mpact of rapid and aggressive therapies to reverse decom-
ensation (11,12).
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atients with HF account for about one-tenth of the
edicare population but over one-third of all Medicare
pending, presenting an unsustainable burden as the popu-
ation ages. The Get With The Guidelines program from
he American Heart Association focuses on translating HF
herapies from major trials into routine hospital practice,
nd serves as 1 example of a range of interventions to
mprove outcomes through the H2H (hospital to home)
ransition advocated by the American College of Cardiol-
gy. However, the goal of decreasing HF admissions is
indered by uncoupled systems for in-hospital and outpa-
ient management, where care is fragmented between mul-
iple providers.
The current study underlines the need to look through the
aze of the hospital burden at the “who” and “why” of
ospitalizations and recognize 2 groups of patients. Patients
ho carry a diagnosis of HF without previous HF hospital-
zation are more likely to be hospitalized for conditions that are
ot HF. Surely, interventions should differ in the patient group
efined by recent HF hospitalization for whom the likelihood
f HF as the next admission diagnosis rises after each read-
ission (Table 1). It is likely that hospitals will move to
houlder some of the clinical and financial burden of transition
are during the month after discharge for these patients at
ighest risk of HF readmissions.
This study reminds us that care should be tailored to fit
oals and risks for individual patients, not for diagnoses or
or the specialists who treat them. The comorbidities that
rive many hospitalizations in general communities are
xclusions for most trials from which our bases of evidence
erive. It is not entirely certain that the promised benefits of
ate and Cause of Hospitalizations in Relation to 1-Year MortalityTable 1 Rate and Cause of Hospitalizations in Relation to 1-Ye
After
Hospit
% of patients hospitalized for any reason 30% in 2–3
27% in 3 m
38% in 6 m
67% (3)
% of patients hospitalized for HF 22% in 2 y
% of patients hospitalized for cardiovascular reasons 43% (3)
42% (16)
% of hospitalized patients with HF as the primary cause —
% of hospitalized patients with cardiovascular diseases
as the primary cause
64% (3)
Mortality 37% (3)
31% (14)
42% (16)
29% (EF 
32% (EF 
ote: all data are for annual rates unless otherwise indicated. *Estimated from Figure 2 in Lee et
EF  ejection fraction; HF  heart failure.ospitalization reduction are realized when recommendedherapies are prescribed in the real world for patients with
F as one of multiple diagnoses.
As we have advanced successfully from the anecdote to the
ases of evidence, some vital information has perhaps been lost
n the transition from individuals to averages. The cluster of
atients with accelerating hospitalizations merits specific re-
valuation of recommended therapies and timing of discussion
egarding patient preferences near the end of the journey. Care
or the whole patient remains more than the sum of recom-
ended therapies for separate diagnoses. “Who” and “why”
ill always be important questions.
eprint requests and correspondence: Dr. Lynne Warner
tevenson, Brigham and Women’s Hospital Cardiovascular Divi-
ion, 75 Francis Street, Boston, Massachusetts 02115. E-mail:
Stevenson@partners.org.
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